Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells

Leukemia Research

Volumn 21, Issue 2, 1997, Pages 163-172

  Vial, Jean Philippe ^a   Belloc, Francis ^b   Dumain, Patrice ^b   Besnard, Sabine ^a   Lacombe, Francis ^c   Boisseau, Michel R ^b   Reiffers, Josy ^c   Bernard, Philippe ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c CNRS Bordeaux Segalen University   (France)

Author keywords

Antitumoral agents; Apoptosis; Cell cycle; Flow cytometry; Leukaemic cells

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; COLCHICINE; CYTARABINE; DAUNORUBICIN; DEMECOLCINE; IDARUBICIN; MITOXANTRONE;

APOPTOSIS; ARTICLE; CELL CYCLE; CYTOSTASIS; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0031080192     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00102-6     Document Type: Article

References (30)

1. 1. Arends M. J. & Wyllie A. H. (1991) Apoptosis: Mechanisms and roles in pathology. Int. Rev. exp. Pathol. 32, 223.
2. 2. Golstein P. (1991) Mort programmée et terrain cellulaire. Med. Sci. 7, 681.
3. 3. Wyllie A. H. (1993) Apoptosis (The 1992 Frank Rose Memorial Lecture). Br. J. Cancer 67, 205.
4. 4. Wyllie A. H. (1992) Apoptosis and the regulation of cell numbers in normal and neoplasic tissues: an overview. Cancer Metast. Rev. 11, 95.
5. 5. Yoshida Y. (1993) Hypothesis: Apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplasic syndrome. Leukemia 7, 144.
6. 6. Desoize B. & Sen S. (1992) L'apoptose ou mort cellulaire programmée: concepts, mécanismes et apports en cancérologie. Bull. Cancer 79, 43.
7. 7. Gershenson L. E. & Rotello R. J. (1992) Apoptosis: a different type of cell death. Fedn Am. Soc. exp. Biol. J. 6, 2450.
8. 8. Parchment R. E. (1993) The implications of a unified theory of programmed cell death, polyamines, oxyradicals, and histogenesis in the embryo. Int. J. Devl Biol. 37, 75.
9. 9. Koury M. J. (1992) Programmed cell death (apoptosis) in hematopoiesis. Exp. Hematol. 20, 391.
10. 10. Kahn A. & Briand P. (1993) L'apoptose, une mort programmée ou une prolifération avortée? Med. Sci. 9, 663.
11. 11. Piechaczyk M. (1992) Myc: le paradoxe d'un oncogène induisant la mort cellulaire programmée. Med. Sci. 8, 586.
12. 12. Sachs L. & Lotem J. (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82, 15.
13. 13. Belloc F., Dumain P., Boisseau M. R., Jalloustre C., Reiffers J., Bernard P. & Lacombe F. (1994) A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 17, 59.
14. 14. Lacombe F., Belloc F., Bernard P. & Boisseau M. R. (1988) Evaluation of four methods of DNA distribution data analysis based on bromodeoxyuridine/DNA bivariate data. Cytometry 9, 245.
15. 15. Robert J. & Gianni L. (1993) Pharmacokinetics and metabolism of anthracyclines. Cancer Surv. 17, 219.
16. 16. Vial J. P., Belloc F., Schmitt V., Dumain P., Lacombe F., Boisseau M. R., Bernard P. & Reiffers J. (1994) Etude par cytométrie en flux de l'apoptose induite in vitro par les anthracyclines l'Ara-C et la mitoxantrone sur la lignée cellulaire U 937. Bull. Cancer 81, 972.
17. 17. Bazar L. S. & Deeg H. J. (1992) Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp. Hematol. 2, 80.
18. 18. Bhalla K., Ibrado A. M., Tourkina E., Tang C., Grant S., Bullock G., Huang Y., Ponnathpur V. & Mahoney E. (1993) High-dose Mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 82, 3133.
19. 19. Gunji H., Kharbanda S. & Kufe D. (1991) Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-arabinofuranosylcytosine. Cancer Res. 51, 741.
20. 20. Minderman H., Brons P. P. T., Linssen P. C. M., Pennings A. H. M., Wessels J. M. C., Boezeman J. B. M. & Haanen C. (1991) Effects of doxorubicin exposure on cell-cycle kinetics of human leukemia cells studied by bivariate flow cytometric measurement of 5-iodo-2-deoxyuridine incorporation and DNA content. Exp. Hematol. 19, 1008.
21. 21. Skladanovski A. & Konopa J. (1993) Adriamycin and Daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmac. 46, 375.
22. 22. Lavelle F. (1987) Structure et activité des anthracyclines. Path. Biol. 35, 11.
23. 23. Ling Y. H., Priebe W. & Perez-Soler R. (1993) Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 53, 1845.
24. 24. Canal P., Attal M., Chatelut E., Guichard S., Huguet F., Muller C. & Schlaifer D. (1993) Plasma and cellular pharmacokinetics of mitoxantrone on high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Res. 53, 4850.
25. 25. Del Bino G., Li X., Traganos F. & Darzynkiewicz Z. (1993) Altered susceptibility of differentiating HL-60 cells to apoptosis induced by anticancer drugs. Leukemia 8, 281.
26. 26. Gorczyca W., Gong J., Ardelt B., Traganos F. & Darzynkiewicz Z. (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53, 3186.
27. 27. Gorczyca W., Melamed M. R. & Darzynkiewicz Z. (1993) Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay. Toxic. Lett. 67, 249.
28. 28. Lacombe F., Belloc F., Dumain P., Puntous M., Lopez F., Bernard P., Boisseau M. R. & Reiffers J. (1992) Quantification of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms. Cytometry 13, 730.
29. 29. Lacombe F., Belloc F., Dumain P., Saux M. C., Bernard P. & Reiffers J. (1994) Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry. Blood 84, 716.
30. 30. Robert J., Rigal-Huguet F. & Hurteloup P. (1992) Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients. Hematol. Oncol. 10, 111.